Interferon alfa-2b

From Wikipedia, the free encyclopedia
(Redirected from Intron A)

Template:Short description Template:Short description Page Template:Infobox drug/styles.css has no content.

Page Module:Infobox/styles.css has no content.

Interferon alfa-2b
Clinical data
MedlinePlusa690006
License dataPage Template:Plainlist/styles.css has no content.
Routes of
administration		Subcutaneous, intramuscular
ATC codePage Template:Plainlist/styles.css has no content.
Legal status
Legal statusPage Template:Plainlist/styles.css has no content.
Identifiers
CAS NumberPage Template:Plainlist/styles.css has no content.
PubChem CIDPage Template:Plainlist/styles.css has no content.
PubChem SIDPage Template:Plainlist/styles.css has no content.
IUPHAR/BPSPage Template:Plainlist/styles.css has no content.
DrugBankPage Template:Plainlist/styles.css has no content.
ChemSpiderPage Template:Plainlist/styles.css has no content.
UNIIPage Template:Plainlist/styles.css has no content.
KEGGPage Template:Plainlist/styles.css has no content.
ChEBIPage Template:Plainlist/styles.css has no content.
ChEMBLPage Template:Plainlist/styles.css has no content.
NIAID ChemDBPage Template:Plainlist/styles.css has no content.
PDB ligandPage Template:Plainlist/styles.css has no content.
CompTox Dashboard (EPA)Page Template:Plainlist/styles.css has no content.
Chemical and physical data
3D model (JSmol)Page Template:Plainlist/styles.css has no content.
Data page
Template:Infobox drug/data page link
Page Template:Nobold/styles.css has no content. ☒NcheckY (what is this?)Page Template:Nobold/styles.css has no content.  (verify)

Interferon alfa-2b is an antiviral or antineoplastic drug. It is a recombinant form of the protein Interferon alpha-2 that was originally sequenced and produced recombinantly in E. coli[1] in the laboratory of Charles Weissmann at the University of Zurich, in 1980.[2][3] It was developed at Biogen, and ultimately marketed by Schering-Plough under the trade name Intron-A. It was also produced in 1986 in recombinant human form, in the Center for Genetic Engineering and Biotechnology of Havana, Cuba, under the name Heberon Alfa R.[4]

It has been used for a wide range of indications, including viral infections and cancers. This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, Behçet's disease, chronic myelogenous leukemia, multiple myeloma, follicular lymphoma, carcinoid tumor, mastocytosis and melanoma.[citation needed]

The medication is being used in clinical trials to treat patients with SARS-CoV-2[5] and there are published results in the peer-reviewed scientific literature.[6]

So far, two non-peer reviewed research articles have been published. One study at the University of Texas Medical Branch, Galveston, showed evidence of a direct anti-viral effect of Interferon alpha against novel Coronavirus in vitro. The study demonstrated around 10,000 fold reduction in the quantity of virus that was pre-treated with Interferon alpha 48 hours earlier. A second study by universities in China, Australia and Canada analysed 77 moderate COVID-19 subjects in Wuhan and observed that those who received Interferon alpha-2b showed a significant reduction in the duration of virus shedding period and even in levels of the inflammatory cytokine, IL-6.[7][8]

This drug is also used off-label in cats and dogs, both by injection and orally.[9] The cross-species nature of IFN-α allow it to work in non-human animals,[10] but the period of usefulness is limited by the production of antibodies against this foreign protein.[9]

Interferon alfa-2b products[11]
Product Manufacturer Features Special uses
Alpharona Pharmaclon
Intron-A/IntronA Schering-Plough
Realderon Teva
Reaferon EC GNC Vector
Reaferon EC-Lipint Vector-Medica liposomal
Infagel Vector-Medica ointment
Recolin Vector-Medica
Altevir Bioprocess subsidiary liquid, free of HSA
Kipferon Alfarm combination with IgM, IgA, IgG
Giaferon A/S Vitafarma
Genferon Biocad
Opthalamoferon Firn-M with dimedrol eye infections
Heberon Alfa R BioCubaFarma, Cuban-Chinese joint venture ChangHeber[12][13] severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[14]

See also

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content.Nagata S, Taira H, Hall A, Johnsrud L, Streuli M, Ecsödi J, et al. (March 1980). "Synthesis in E. coli of a polypeptide with human leukocyte interferon activity". Nature. 284 (5754): 316–320. Bibcode:1980Natur.284..316N. doi:10.1038/284316a0. PMID 6987533. S2CID 4310807.
  2. ^ Page Module:Citation/CS1/styles.css has no content.Weissmann C (2001). "Recombinant interferon - the 20th anniversary". In Buckel P (ed.). Recombinant Protein Drugs. Milestones in Drug Therapy. Basel: Birkhäuser. pp. 3–41. doi:10.1007/978-3-0348-8346-7_1. ISBN 978-3-0348-8346-7.
  3. ^ Page Module:Citation/CS1/styles.css has no content.Mantei N, Schwarzstein M, Streuli M, Panem S, Nagata S, Weissmann C (June 1980). "The nucleotide sequence of a cloned human leukocyte interferon cDNA". Gene. 10 (1): 1–10. doi:10.1016/0378-1119(80)90137-7. PMID 6157600.
  4. ^ Page Module:Citation/CS1/styles.css has no content.Nodarse-Cuní H, López-Saura PA (2017). "Cuban interferon alpha-2b. Thirty years as an effective and safe drug". Biotecnología Aplicada. 34 (1): 1211–1217. ISSN 1027-2852.
  5. ^ Page Module:Citation/CS1/styles.css has no content.O'Connor T (March 24, 2020). "Cuba uses "wonder drug" to fight coronavirus around the world despite U.S. sanctions". Newsweek.
  6. ^ Page Module:Citation/CS1/styles.css has no content.Pereda R, González D, Rivero HB, Rivero JC, Pérez A, Lopez LD, et al. (December 2020). "Therapeutic Effectiveness of Interferon Alpha 2b Treatment for COVID-19 Patient Recovery". Journal of Interferon & Cytokine Research. 40 (12): 578–588. doi:10.1089/jir.2020.0188. PMID 33337933. S2CID 229324680.
  7. ^ Page Module:Citation/CS1/styles.css has no content."Zydus to test use of Hepatitis C medicine for virus". The Times of India. 21 April 2020.
  8. ^ Page Module:Citation/CS1/styles.css has no content."BRIEF-Zydus Explores Biologicals Route to Treat Coronavirus with Interferon Alpha-2B". Reuters. 20 April 2020.
  9. ^ a b Page Module:Citation/CS1/styles.css has no content.Forney B. "Interferon Alpha-2B for Veterinary Use". Wedgewood Pharmacy. Archived from the original on 2021-10-19.
  10. ^ Page Module:Citation/CS1/styles.css has no content.Yang LM, Xue QH, Sun L, Zhu YP, Liu WJ (February 2007). "Cloning and characterization of a novel feline IFN-omega". Journal of Interferon & Cytokine Research. 27 (2): 119–127. doi:10.1089/jir.2006.0094. PMID 17316139.
  11. ^ Page Module:Citation/CS1/styles.css has no content.Bairamashvili DI, Rabinovich ML (2007). "Russia through the prism of the world biopharmaceutical market" (PDF). Biotechnol. J. 2 (7): 801–817. doi:10.1002/biot.200700091. PMID 17615600. S2CID 26770545. Archived from the original (PDF) on 2012-02-24. Retrieved 2009-06-14.
  12. ^ Page Module:Citation/CS1/styles.css has no content.Makichuk D (18 April 2020). "Covid contenders: Viral drugs that offer hope". Asia Times.
  13. ^ Page Module:Citation/CS1/styles.css has no content."The famous Cuban interferon vs the SARS-CoV-2 coronavirus". 19 March 2020.
  14. ^ Page Module:Citation/CS1/styles.css has no content."Medikament aus Kuba zur Behandlung des Coronavirus bald auch in Deutschland?". 30 March 2020.

Further reading

Page Template:Refbegin/styles.css has no content.

Page Module:Side box/styles.css has no content.Page Template:Sister project/styles.css has no content.

Page Template:Plainlist/styles.css has no content.
Script error: No such module "Sister project logo".
Wikimedia Commons has media related to [[commons:Template:If then show|Template:If then show]].

Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Template:Cytokine receptor modulators

Retrieved from "https://cosmopedia.co/index.php?title=Interferon_alfa-2b&oldid=4917447"